post-transplant lymphoproliferative disorder
human disease
Press Enter · cited answer in seconds
0 sources
Summary
post-transplant lymphoproliferative disorder is a class of disease[1]. It draws 281 Wikipedia views per month (class of disease category, ranking #613 of 1,968).[2]
Key Facts
- Subclass of: lymphoproliferative disorders[3], transplant-related disease[4], T-cell lymphoma[5], immunodeficiency-associated lymphoproliferative disease[6]
- Prevalence: 0.0003[7]
- NCI Thesaurus ID: C4727[8]
- Health specialty: immunology[9]
- Drug or therapy used for treatment: rituximab[10], doxorubicin[11]
- Age of onset: any age[12]
- Exact match: http://www.orpha.net/ORDO/Orphanet_70568[13], http://purl.obolibrary.org/obo/DOID_3836[14], http://identifiers.org/doid/DOID:3836[15]
- On focus list of Wikimedia project: WikiProject Medicine[16]
- Has phenotype: weight loss[17], fever[18], lymphadenopathy[19], fatigue[20], snoring[21], night sweats[22], malaise[23], diarrhea[24], abdominal pain[25], gastrointestinal bleeding[26], hypoalbuminemia[27], hepatitis[28]
- P14914: D70568[29]
Why It Matters
post-transplant lymphoproliferative disorder is known by 8 alternative names across languages and contexts.[30]